糖尿病是否应作为双侧内乳动脉搭桥的禁忌证?
该多中心回顾性分析纳入1992至2014年间7个医疗中心的47984例连续冠状动脉旁路移植术(CABG)患者,其中1482例使用双侧内乳动脉(BIMA),经倾向性匹配后纳入430例糖尿病患者(单侧内乳动脉SIMA组217例,BIMA组213例)。中位随访9.3年,BIMA组与SIMA组相比长期生存显著改善(风险比0.75,95%置信区间0.57至0.98,p=0.034),且两组住院死亡率和纵隔炎或胸骨裂开率无差异。
要点
- 糖尿病患者BIMA搭桥不增加住院死亡率(p=0.758)或纵隔炎/胸骨裂开率(p=0.503)。
- BIMA组长期生存优于SIMA组(风险比0.75,95%置信区间0.57至0.98,p=0.034)。
- 两组中位住院时间均为5天(范围4至7天)。
核心结论
- 糖尿病患者行CABG时,使用BIMA搭桥不增加住院并发症或死亡率,且与SIMA相比具有长期生存优势。
研究设计与样本
- 多中心回顾性分析,纳入1992至2014年间7个医疗中心的47984例连续CABG患者。
- 共识别1482例BIMA搭桥,经倾向性匹配将1297例BIMA患者与1297例SIMA患者匹配。
- 本分析队列取自匹配数据,纳入430例糖尿病患者:SIMA组217例,BIMA组213例。
主要发现
- 中位随访时间9.3年(范围4.3至13.9年)。
- 两组纵隔炎或胸骨裂开率无差异(p=0.503),住院死亡率无差异(p=0.758)。
- 两组中位住院时间均为5天(范围4至7天)。
- BIMA组与SIMA组相比长期生存显著改善(风险比0.75,95%置信区间0.57至0.98,p=0.034)。
临床怎么用
- 作者认为,糖尿病患者应更频繁地考虑BIMA搭桥。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: This study evaluates the influence of bilateral internal mammary artery (BIMA) versus single internal mammary artery (SIMA) grafting on postoperative morbidity and long-term survival among diabetic patients undergoing coronary artery bypass grafting (CABG). METHODS: A multicenter, retrospective analysis of 47,984 consecutive CABGs performed from 1992 to 2014 at 7 medical centers was conducted. Among the study population, 1,482 CABGs with BIMA were identified, and 1,297 BIMA patients were propensity-matched to 1,297 SIMA patients. The study cohort for this analysis, drawn from matched data, included 430 diabetic patients: 217 SIMA and 213 BIMA. The primary endpoint was long-term survival. Secondary endpoints included postoperative morbidity, length of stay, and in-hospital mortality. RESULTS: The median duration of follow-up was 9.3 (range, 4.3 to 13.9) years. Among propensity-matched diabetic patients, there was no significant difference in age, body mass index, or major baseline comorbidities. The groups were also well matched on the number of diseased coronary arteries and number of distal anastomoses performed. There was no difference in the rate of mediastinitis or sternal dehiscence (p = 0.503) or in-hospital mortality (p = 0.758) between groups. Both groups had a similar median length of stay of 5 (range, 4 to 7) days. Diabetic patients who received a BIMA had significantly improved long-term survival when compared with SIMA patients (hazard ratio 0.75 [95% confidence interval 0.57 to 0.98], p = 0.034). CONCLUSIONS: Among diabetics undergoing CABG, use of BIMA grafting does not result in increased in-hospital morbidity or mortality and confers a long-term survival advantage when compared with SIMA grafting. Thus, diabetic patients should be considered for BIMA grafting more frequently.
引用
- Iribarne A, Westbrook BM, Malenka DJ, et al. Should Diabetes Be a Contraindication to Bilateral Internal Mammary Artery Grafting? Ann Thorac Surg. 2017. PMID: 29223418. doi:10.1016/j.athoracsur.2017.08.054
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。